VITROLIFE A/S: Financial statements 2013
CVR: 27406793
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
VITROLIFE A/S (CVR 27406793) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 22,464,717 and a net result of DKK -34,101,319 compared with DKK -14,069,985 the year before. That is a decrease of 6.2% compared with the year before. Equity in the 2013 report amounted to DKK 49,762,909. The solvency ratio was 35.6%. The company had 72 employees in the financial year.
- Gross Profit
- DKK 22,464,717
- Profit/Loss
- DKK -34,101,319
- Equity
- DKK 49,762,909
- Total Assets
- DKK 139,853,140
- Employees
- 72
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 22.5 mio. | -34.1 mio. | 49.8 mio. | 72 |
| 2012 | - | 24 mio. | -14.1 mio. | 78.1 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of June 14, 2013, Michael Reeslev is registered as adm. dir. of VITROLIFE A/S.
As of June 14, 2013, Jens Kristian Ellekilde Gundersen has stepped down as director of VITROLIFE A/S.
VITROLIFE A/S has published its annual report for 2012. Gross profit came to DKK 23,954,175, and the net result was DKK -14,069,985.
As of May 30, 2013, Christian Grøndahl has joined the board of directors of VITROLIFE A/S.
As of May 30, 2013, Tom Henning Riisom has left the board of directors of VITROLIFE A/S.
As of March 1, 2013, Claus Jørgensen has joined the board of directors of VITROLIFE A/S.
About VITROLIFE A/S
VITROLIFE A/S is a Danish company of the type Aktieselskab based in Viby J, founded in 2003. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named UNISENSE FERTILITECH A/S and UNISENSE FERTILITECH ApS. The management consists of Dag Erik Rickard Ericsson. The board consists of Sten Jakob Hedén (chair), Dag Erik Rickard Ericsson and Tom Faes. The company is owned by Vitrolife AB. The company has 114 employees (2026). In 2025, the company reported a gross profit of DKK 228,406,323 and a net result of DKK 110,485,853 compared with DKK 130,285,262 the year before. Equity in the 2025 report amounted to DKK 327,839,900.